Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Galmed Pharmaceuticals Ltd. (GLMD) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.72M |
|
-- |
|
-- |
|
$2.77M |
|
$-2.77M |
|
$0.05M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.72M |
|
$-2.77M |
|
$-2.79M |
|
0.95M |
|
0.95M |
|
$-2.86 |
|
$-2.86 |
|
| Balance Sheet Financials | |
$11.71M |
|
$0.05M |
|
$6.57M |
|
$18.28M |
|
$2.81M |
|
-- |
|
$2.73M |
|
$5.54M |
|
$12.74M |
|
$6.33M |
|
$12.74M |
|
1.00M |
|
| Cash Flow Statement Financials | |
$-4.66M |
|
$2.40M |
|
$1.20M |
|
$4.11M |
|
$3.04M |
|
$-1.06M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.38% |
|
-43.00% |
|
-14.89% |
|
-21.38% |
|
$12.73 |
|
$-4.90 |
|
$-4.90 |
|